Viridian Therapeutics, Inc.\DE (VRDN) Change in Acquisitions & Divestments (2018 - 2026)

Viridian Therapeutics, Inc.\DE's Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $168.6 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 1.63% year-over-year to $168.6 million; the TTM figure through Mar 2026 stood at $539.4 million (down 2.94% YoY), while the FY2025 annual figure was $542.2 million, up 16.12% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $168.6 million, up from $99.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $171.4 million in Q1 2025, with the low at $14.2 million in Q1 2022.
• The 5-year median for Change in Acquisitions & Divestments is $99.0 million (2025), against an average of $94.2 million.
• Peak annual rise in Change in Acquisitions & Divestments reached 2968.21% in 2022, while the deepest fall reached 78.92% in 2022.
• Viridian Therapeutics, Inc.\DE's Change in Acquisitions & Divestments stood at $37.7 million in 2022, then surged by 172.76% to $102.8 million in 2023, then rose by 15.7% to $119.0 million in 2024, then retreated by 16.78% to $99.0 million in 2025, then soared by 70.29% to $168.6 million in 2026.
• Business Quant data shows VRDN's Change in Acquisitions & Divestments at $168.6 million in Q1 2026, $99.0 million in Q4 2025, and $140.3 million in Q3 2025.